Web1 day ago · CRISPR Therapeutics (CRSP) jumped Thursday after Cantor Fitzgerald launched its coverage with an Overweight rating and a $72 per share target. Find out the reasons. WebApr 10, 2024 · According to 33 stock analysts, the average 12-month stock price forecast for CRSP stock is $ 88.13 , which predicts an increase of 94.85%. The lowest target is $ 39.39 and the highest is $ 231. On average, analysts rate CRSP stock as a buy. Analyst Consensus: Buy Analyst Ratings

CRISPR Therapeutics AG (CRSP) - Stock Analysis

Web23 hours ago · Shares of CRISPR Therapeutics (CRSP 16.31%) were up 15% Thursday morning, a day after a drug-pricing group said the company's single-dose therapy for … WebApr 13, 2024 · Shares of CRISPR Therapeutics AG ( NASDAQ:CRSP - Get Rating) have received a consensus rating of "Hold" from the twenty analysts that are presently … god bless you 歌詞 セリフ

Why Shares of CRISPR Therapeutics Jumped Thursday

Web2 days ago · CRISPR Therapeutics (CRSP) (Delayed Data from NSDQ) $44.80 USD +1.09 (2.49%) Updated Apr 5, 2024 03:59 PM ET After-Market: $44.60 -0.20 (-0.45%) 7:58 PM ET Add to portfolio Zacks Rank: 2-Buy 2... WebCRSP Analyst Ratings Moderate Buy 17 Ratings 9 Buy 7 Hold 1 Sell Based on 17 analysts giving stock ratings to Crispr Therapeutics AG in the past 3 months CRSP … Web1 day ago · Three of ANEW's underlying holdings with notable upside to their analyst target prices are CRISPR Therapeutics AG (Symbol: CRSP), Veracyte Inc (Symbol: VCYT), … bonner springs event space